Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 214

1.

New Insights into the Roles of Monocytes/Macrophages in Cardiovascular Calcification Associated with Chronic Kidney Disease.

Hénaut L, Candellier A, Boudot C, Grissi M, Mentaverri R, Choukroun G, Brazier M, Kamel S, Massy ZA.

Toxins (Basel). 2019 Sep 12;11(9). pii: E529. doi: 10.3390/toxins11090529. Review.

2.

PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study: study protocol for a randomized controlled study.

Gaiffe E, Crepin T, Bamoulid J, Courivaud C, Büchler M, Cassuto E, Albano L, Chemouny JM, Choukroun G, Hazzan M, Kessler L, Legendre C, Le Meur Y, Ouali N, Thierry A, Anota A, Nerich V, Limat S, Bonnetain F, Vernerey D, Ducloux D.

Trials. 2019 Jun 21;20(1):375. doi: 10.1186/s13063-019-3392-6.

3.

The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.

Bennis Y, Cluet Y, Titeca-Beauport D, El Esper N, Ureña P, Bodeau S, Combe C, Dussol B, Fouque D, Choukroun G, Liabeuf S.

Toxins (Basel). 2019 May 17;11(5). pii: E279. doi: 10.3390/toxins11050279.

4.

Risk Factors for Early Graft Failure and Death After Kidney Transplantation in Recipients Older Than 70 Years.

Lemoine M, Titeca Beauport D, Lobbedez T, Choukroun G, Hurault de Ligny B, Hazzan M, Guerrot D, Bertrand D.

Kidney Int Rep. 2019 Jan 28;4(5):656-666. doi: 10.1016/j.ekir.2019.01.014. eCollection 2019 May.

5.

Cellular and molecular mechanisms associated with ischemic stroke severity in female mice with chronic kidney disease.

Hénaut L, Grissi M, Brazier F, Assem M, Poirot-Leclercq S, Lenglet G, Boudot C, Avondo C, Boullier A, Choukroun G, Massy ZA, Kamel S, Chillon JM.

Sci Rep. 2019 Apr 23;9(1):6432. doi: 10.1038/s41598-019-42933-0.

6.
7.

Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppression.

Snanoudj R, Kamar N, Cassuto E, Caillard S, Metzger M, Merville P, Thierry A, Jollet I, Grimbert P, Anglicheau D, Hazzan M, Choukroun G, Hurault De Ligny B, Janbon B, Vuiblet V, Devys A, Le Meur Y, Delahousse M, Morelon E, Bailly E, Girerd S, Amokrane K, Legendre C, Hertig A, Rondeau E, Taupin JL.

Kidney Int. 2019 Jun;95(6):1471-1485. doi: 10.1016/j.kint.2018.12.029. Epub 2019 Mar 5.

PMID:
30955869
8.

Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients.

Fourdinier O, Schepers E, Metzinger-Le Meuth V, Glorieux G, Liabeuf S, Verbeke F, Vanholder R, Brigant B, Pletinck A, Diouf M, Burtey S, Choukroun G, Massy ZA, Metzinger L; European Uremic Toxin Work Group-EUTox.

Sci Rep. 2019 Mar 14;9(1):4477. doi: 10.1038/s41598-019-41101-8.

9.

Endothelial cells exposed to phosphate and indoxyl sulphate promote vascular calcification through interleukin-8 secretion.

Bouabdallah J, Zibara K, Issa H, Lenglet G, Kchour G, Caus T, Six I, Choukroun G, Kamel S, Bennis Y.

Nephrol Dial Transplant. 2019 Jul 1;34(7):1125-1134. doi: 10.1093/ndt/gfy325.

PMID:
30481303
10.

[What do registries compared to clinical trials tell us?]

Choukroun G, Moulin B.

Nephrol Ther. 2018 Nov;14(6S):6S7-6S11. doi: 10.1016/S1769-7255(18)30645-X. Review. French.

PMID:
30473063
11.

Early predictors of one-year mortality in patients over 65 presenting with ANCA-associated renal vasculitis: a retrospective, multicentre study.

Titeca-Beauport D, Francois A, Lobbedez T, Guerrot D, Launay D, Vrigneaud L, Daroux M, Lebas C, Bienvenu B, Hachulla E, Diouf M, Choukroun G.

BMC Nephrol. 2018 Nov 9;19(1):317. doi: 10.1186/s12882-018-1102-3.

12.

Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review.

Demey B, Tinez C, François C, Helle F, Choukroun G, Duverlie G, Castelain S, Brochot E.

J Clin Virol. 2018 Dec;109:6-12. doi: 10.1016/j.jcv.2018.10.002. Epub 2018 Oct 12.

PMID:
30343190
13.

BK polyomavirus in the urine for follow-up of kidney transplant recipients.

Brochot E, Descamps V, Handala L, Faucher J, Choukroun G, Helle F, Castelain S, François C, Duverlie G, Touzé A.

Clin Microbiol Infect. 2019 Jan;25(1):112.e1-112.e5. doi: 10.1016/j.cmi.2018.07.027. Epub 2018 Aug 1.

PMID:
30076973
14.

Cognitive Impairments and Dysexecutive Behavioral Disorders in Chronic Kidney Disease.

Puy L, Bugnicourt JM, Liabeuf S, Desjardins L, Roussel M, Diouf M, Chillon JM, Choukroun G, Massy ZA, Godefroy O.

J Neuropsychiatry Clin Neurosci. 2018 Fall;30(4):310-317. doi: 10.1176/appi.neuropsych.18030047. Epub 2018 Jul 26.

PMID:
30045680
15.

Recurrence of Renal Cell Cancer After Renal Transplantation in a Multicenter French Cohort.

Cognard N, Anglicheau D, Gatault P, Girerd S, Essig M, Hurault de Ligny B, Le Meur Y, Le Roy F, Garrouste C, Thierry A, Colosio C, Rivalan J, Sayegh J, Choukroun G, Moulin B, Caillard S.

Transplantation. 2018 May;102(5):860-867. doi: 10.1097/TP.0000000000002009.

PMID:
29215458
16.

Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKD.

Liabeuf S, Ryckelynck JP, El Esper N, Ureña P, Combe C, Dussol B, Fouque D, Vanhille P, Frimat L, Thervet E, Mentaverri R, Prié D, Choukroun G; FRENCH Study collaborators.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):1930-1940. doi: 10.2215/CJN.03030317. Epub 2017 Oct 26.

17.

Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study.

Lenglet A, Liabeuf S, Esper NE, Brisset S, Mansour J, Lemaire-Hurtel AS, Mary A, Brazier M, Kamel S, Mentaverri R, Choukroun G, Fournier A, Massy ZA.

Nephrol Dial Transplant. 2017 Sep 1;32(9):1597. doi: 10.1093/ndt/gfx249. No abstract available.

PMID:
29059402
18.

[Survey on the perception of competencies acquired during nephrology resident training in France].

Moranne O, Peraldi MN, Choukroun G, Brunet P, Rondeau É, Moulin B.

Nephrol Ther. 2017 Dec;13(7):518-524. doi: 10.1016/j.nephro.2017.01.026. Epub 2017 Oct 12. French.

PMID:
29031490
19.

Infectious complications of a rituximab-based immunosuppressive regimen in patients with glomerular disease.

Trivin C, Tran A, Moulin B, Choukroun G, Gatault P, Courivaud C, Augusto JF, Ficheux M, Vigneau C, Thervet E, Karras A.

Clin Kidney J. 2017 Aug;10(4):461-469. doi: 10.1093/ckj/sfw101. Epub 2016 Nov 10.

20.

Pronase treatment improves flow cytometry crossmatching results.

Apithy MJ, Desoutter J, Gicquel A, Guiheneuf E, Westeel PF, Lesage A, Piot V, Choukroun G, Guillaume N.

HLA. 2017 Sep;90(3):157-164. doi: 10.1111/tan.13073. Epub 2017 Jun 28.

PMID:
28660746
21.

A potential role of the unfolded protein response in post-transplant cancer.

Bodeau S, Sauzay C, Pluquet O, Choukroun G, Galmiche A.

Clin Sci (Lond). 2017 Jun 22;131(13):1429-1436. doi: 10.1042/CS20170152. Print 2017 Jul 1. Review.

PMID:
28645931
22.

Targeting the Unfolded Protein Response as a Potential Therapeutic Strategy in Renal Carcinoma Cells Exposed to Cyclosporine A.

Bodeau S, Sauzay C, Nyga R, Louandre C, Descamps V, François C, Godin C, Choukroun G, Galmiche A.

Anticancer Res. 2017 Mar;37(3):1049-1057.

PMID:
28314264
23.

[Long-term blood pressure outcome after unilateral adrenalectomy for primary hyperaldosteronism].

Saint F, Prader R, Cordonnier C, Choukroun G, Elesper N, Desailloud R.

Prog Urol. 2017 May;27(6):389-394. doi: 10.1016/j.purol.2017.01.006. Epub 2017 Mar 1. French.

PMID:
28259701
24.

A Simple and Reliable Strategy for BK Virus Subtyping and Subgrouping.

Morel V, Martin E, François C, Helle F, Faucher J, Mourez T, Choukroun G, Duverlie G, Castelain S, Brochot E.

J Clin Microbiol. 2017 Apr;55(4):1177-1185. doi: 10.1128/JCM.01180-16. Epub 2017 Feb 1.

25.

Face Transplantation: Partial Graft Loss of the First Case 10 Years Later.

Morelon E, Petruzzo P, Kanitakis J, Dakpé S, Thaunat O, Dubois V, Choukroun G, Testelin S, Dubernard JM, Badet L, Devauchelle B.

Am J Transplant. 2017 Jul;17(7):1935-1940. doi: 10.1111/ajt.14218. Epub 2017 Mar 9.

26.

Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy.

Chauvet S, Frémeaux-Bacchi V, Petitprez F, Karras A, Daniel L, Burtey S, Choukroun G, Delmas Y, Guerrot D, François A, Le Quintrec M, Javaugue V, Ribes D, Vrigneaud L, Arnulf B, Goujon JM, Ronco P, Touchard G, Bridoux F.

Blood. 2017 Mar 16;129(11):1437-1447. doi: 10.1182/blood-2016-08-737163. Epub 2017 Jan 9.

PMID:
28069603
27.

The drugs that mostly frequently induce acute kidney injury: a case - noncase study of a pharmacovigilance database.

Pierson-Marchandise M, Gras V, Moragny J, Micallef J, Gaboriau L, Picard S, Choukroun G, Masmoudi K, Liabeuf S; French National Network of Pharmacovigilance Centres.

Br J Clin Pharmacol. 2017 Jun;83(6):1341-1349. doi: 10.1111/bcp.13216. Epub 2017 Mar 14.

28.

Plasma Exchange in the Management of Catastrophic Antiphospholipid Syndrome.

Titeca-Beauport D, Salle V, Kontar L, Maizel J, Choukroun G.

Case Rep Crit Care. 2016;2016:5375080. Epub 2016 Oct 19.

29.

The association between killer-cell immunoglobulin-like receptor (KIR) and KIR ligand genotypes and the likelihood of BK virus replication after kidney transplantation.

Brochot E, Desoutter J, Presne C, De Araujo I, Flahaut G, Castelain S, Westeel PF, Choukroun G, Guillaume N.

Transpl Int. 2016 Nov;29(11):1168-1175. doi: 10.1111/tri.12820. Epub 2016 Sep 12.

30.
31.

Predictive Modeling of Tacrolimus Dose Requirement Based on High-Throughput Genetic Screening.

Damon C, Luck M, Toullec L, Etienne I, Buchler M, Hurault de Ligny B, Choukroun G, Thierry A, Vigneau C, Moulin B, Heng AE, Subra JF, Legendre C, Monnot A, Yartseva A, Bateson M, Laurent-Puig P, Anglicheau D, Beaune P, Loriot MA, Thervet E, Pallet N.

Am J Transplant. 2017 Apr;17(4):1008-1019. doi: 10.1111/ajt.14040. Epub 2016 Oct 7.

32.

Quiz Page July 2016: Hyponatremia in a Patient With Central Nervous System Lymphoma.

Brault C, Flahaut G, Maizel J, Choukroun G.

Am J Kidney Dis. 2016 Jul;68(1):A17-9. doi: 10.1053/j.ajkd.2016.03.420. No abstract available.

PMID:
27343809
33.

Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study.

Lenglet A, Liabeuf S, El Esper N, Brisset S, Mansour J, Lemaire-Hurtel AS, Mary A, Brazier M, Kamel S, Mentaverri R, Choukroun G, Fournier A, Massy ZA.

Nephrol Dial Transplant. 2017 May 1;32(5):870-879. doi: 10.1093/ndt/gfw042.

PMID:
27190329
34.

Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 Genotype.

Pallet N, Etienne I, Buchler M, Bailly E, Hurault de Ligny B, Choukroun G, Colosio C, Thierry A, Vigneau C, Moulin B, Le Meur Y, Heng AE, Legendre C, Beaune P, Loriot MA, Thervet E.

Am J Transplant. 2016 Sep;16(9):2670-5. doi: 10.1111/ajt.13788. Epub 2016 Apr 8.

35.

Once-Monthly Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Hemodialysis-Dependent Chronic Kidney Disease: Pooled Data from Phase III Trials.

Locatelli F, Choukroun G, Truman M, Wiggenhauser A, Fliser D.

Adv Ther. 2016 Apr;33(4):610-25. doi: 10.1007/s12325-016-0309-6. Epub 2016 Mar 10.

36.

Levels of Indoxyl Sulfate in Kidney Transplant Patients, and the Relationship With Hard Outcomes.

Liabeuf S, Desjardins L, Massy ZA, Brazier F, Westeel PF, Mazouz H, Titeca-Beauport D, Diouf M, Glorieux G, Vanholder R, Jaureguy M, Choukroun G.

Circ J. 2016;80(3):722-30. doi: 10.1253/circj.CJ-15-0949. Epub 2016 Feb 4.

37.

A Lack of Significant Effect of POR*28 Allelic Variant on Tacrolimus Exposure in Kidney Transplant Recipients.

Jannot AS, Vuillemin X, Etienne I, Buchler M, Hurault de Ligny B, Choukroun G, Colosio C, Thierry A, Vigneau C, Moulin B, Rerolle JP, Heng AE, Subra JF, Legendre C, Beaune P, Loriot MA, Thervet E, Pallet N.

Ther Drug Monit. 2016 Apr;38(2):223-9. doi: 10.1097/FTD.0000000000000267.

PMID:
26829596
38.

Cytosolic phospholipase A2α regulates G1 progression through modulating FOXO1 activity.

Naini SM, Choukroun GJ, Ryan JR, Hentschel DM, Shah JV, Bonventre JV.

FASEB J. 2016 Mar;30(3):1155-70. doi: 10.1096/fj.15-278416. Epub 2015 Dec 7.

39.

Contrôle à long terme de la tension artérielle après surrénalectomie pour hyperaldostéronisme primaire : expérience monocentrique.

Prader R, Cordonnier C, Choukroun G, Desailloud R, Forzini T, Viart L, Saint F.

Prog Urol. 2015 Nov;25(13):857. doi: 10.1016/j.purol.2015.08.285. French. No abstract available.

PMID:
26544479
40.

Vascular expression of annexin A2 in lupus nephritis.

Salle V, Cordonnier C, Schmidt J, Mazière C, Smail A, Attencourt C, Mabille MP, Mazière JC, Makdassi R, Choukroun G, Diouf M, Duhaut P, Ducroix JP.

J Clin Pathol. 2016 Jun;69(6):533-6. doi: 10.1136/jclinpath-2015-203139. Epub 2015 Oct 28.

PMID:
26511441
41.

The Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney Disease.

Liabeuf S, Desjardins L, Diouf M, Temmar M, Renard C, Choukroun G, Massy ZA.

PLoS One. 2015 Jul 16;10(7):e0131707. doi: 10.1371/journal.pone.0131707. eCollection 2015.

42.

[Significance of the urine strip test in case of stunted growth].

Bertholet-Thomas A, Llanas B, Servais A, Bendelac N, Goizet C, Choukroun G, Novo R, Decramer S.

Arch Pediatr. 2015 Jul;22(7):756-62. doi: 10.1016/j.arcped.2015.04.016. Epub 2015 Jun 3. French.

PMID:
26047745
43.

[Cystinosis in adults: A systemic disease].

Servais A, Goizet C, Bertholet-Thomas A, Decramer S, Llanas B, Choukroun G, Novo R.

Nephrol Ther. 2015 Jun;11(3):152-9. doi: 10.1016/j.nephro.2014.12.001. Epub 2015 Mar 11. Review. French.

PMID:
25769364
44.

Glycemic control according to glomerular filtration rate in patients with type 2 diabetes and overt nephropathy: a prospective observational study.

Joly D, Choukroun G, Combe C, Dussol B, Fauvel JP, Halimi JM, Quéré S, Fiquet B.

Diabetes Res Clin Pract. 2015 Apr;108(1):120-7. doi: 10.1016/j.diabres.2015.01.029. Epub 2015 Feb 12.

PMID:
25726333
45.

Kidney transplant recipients carrying the CYP3A4*22 allelic variant have reduced tacrolimus clearance and often reach supratherapeutic tacrolimus concentrations.

Pallet N, Jannot AS, El Bahri M, Etienne I, Buchler M, de Ligny BH, Choukroun G, Colosio C, Thierry A, Vigneau C, Moulin B, Le Meur Y, Heng AE, Subra JF, Legendre C, Beaune P, Alberti C, Loriot MA, Thervet E.

Am J Transplant. 2015 Mar;15(3):800-5. doi: 10.1111/ajt.13059. Epub 2015 Jan 14.

46.

[Fanconi syndrome in a 22-year-old African patient].

Wetzstein M, Jauréguy M, Lanoix JP, Poulain C, Berrou C, Renou M, Cordonnier C, Choukroun G.

Nephrol Ther. 2014 Nov;10(6):471-4. doi: 10.1016/j.nephro.2014.06.004. Epub 2014 Oct 14. French.

PMID:
25439108
47.

[QuiPO: who inject EPO?].

Vigneau C, Le Stum S, Isnard-Bagnis C, Choukroun G, Lemeur Y, Kamar N, Oger E.

Nephrol Ther. 2014 Dec;10(7):507-11. doi: 10.1016/j.nephro.2014.06.003. Epub 2014 Oct 22. French.

PMID:
25439107
48.

Circulating endothelial cells and progenitors as prognostic factors during autoimmune thrombotic thrombocytopenic purpura: results of a prospective multicenter French study.

Widemann A, Pasero C, Arnaud L, Poullin P, Loundou AD, Choukroun G, Sanderson F, Lacroix R, Sabatier F, Coppo P, Dignat-George F, Kaplanski G; ENDO-13 study group.

J Thromb Haemost. 2014 Oct;12(10):1601-9. doi: 10.1111/jth.12681. Epub 2014 Sep 22.

49.

Uremic toxicity and sclerostin in chronic kidney disease patients.

Desjardins L, Liabeuf S, Oliveira RB, Louvet L, Kamel S, Lemke HD, Vanholder R, Choukroun G, Massy ZA; European Uremic Toxin (EUTox) Work Group.

Nephrol Ther. 2014 Nov;10(6):463-70. doi: 10.1016/j.nephro.2014.04.002. Epub 2014 Jul 26.

PMID:
25070604
50.

Ribavirin for chronic hepatitis E virus infection.

Brochot E, Choukroun G, Duverlie G.

N Engl J Med. 2014 Jun 19;370(25):2446-7. doi: 10.1056/NEJMc1405191. No abstract available.

PMID:
24941185

Supplemental Content

Loading ...
Support Center